What is the GLP-1 RA

    GLP-1 is a type of intestinal stimulating insulin secreted by L cells in the intestinal system, which affects insulin secretion under multiple complex effects, thereby affecting blood sugar and digestion, resulting in a series of effects. Weight loss is only one of them, and its indications are extending to liver disease and even Alzheimer's disease. Its full name is Glucagon like peptide-1 receptor receptors, GLP-1RA, also known as GLP-1 glucagon like peptide-1 receptors.

    There are 184 global GLP-1 target research pipelines, including 97, 60, 21, and 6 drugs with single, double, triple, and multiple targets, respectively. The so-called dual targets and multiple targets refer to drugs under the joint action mechanism of multiple targets such as GLP-1/GIP dual targets and GLP/GIP/GCGR triple targets.